-
ASCO 2025: Expert Insights on Endocrine, Cardiac, Ocular, and Dermatologic Toxicities in Breast Cancer Care
02 Jun 2025 17:16 GMT
… common occurrence in patients with breast cancer (BC) being treated … ? in our patients with breast cancer, they impact quality of … in both chemotherapy- and hormone therapy-induced hair loss.1
… of new and emerging breast cancer therapies. 2025 ASCO Annual …
-
Breast Cancer Rates in Indonesia: Gender Insights
02 Jun 2025 13:44 GMT
… parity, breastfeeding practices, and hormonal therapy use, may vary across … achieve meaningful reductions in breast cancer disparities. Indonesia’s demographic … control measures. In confronting breast cancer disparities, multidisciplinary collaboration among …
-
AstraZeneca breast cancer medicine slows disease by over six months
01 Jun 2025 19:20 GMT
… : AstraZeneca Plc's experimental breast cancer pill delayed disease progression by … with a specific type of breast cancer to live for a median … strategy for some breast cancer patients.
Camizestrant works as a hormone therapy to stop …
-
Major discovery about 'invisible' breast tumours that are too small to show up on scans
01 Jun 2025 15:49 GMT
…
Around seven in ten breast cancer patients in the UK … gruelling chemotherapy
Symptoms of breast cancer to look out for … HER-2 negative advanced breast cancer from 23 countries were screened … medicine as well as a hormone therapy.
Researchers found those on …
-
AstraZeneca drug could help keep a common breast cancer at bay
01 Jun 2025 14:46 GMT
… people with advanced breast cancer positive for hormone … first-line therapy, hormone therapy shuts off estrogen signaling … patients whose breast cancer is responsive to hormone therapy develop … positive, HER2-negative breast cancer progressed following initial …
-
Breaking Ground in Breast Cancer: A New Standard in TNBC, a New Way to Target ESR1
31 May 2025 19:48 GMT
… for metastatic triple-negative breast cancer (TNBC), offered clear … hormonal therapy, in women with ER+/HER2-negative (HER2–) breast cancer … for 15% of all breast cancers; about 40% of … with metastatic triple negative breast cancer later in their treatment …
-
‘Breakthrough’ breast cancer treatment can help women live longer
31 May 2025 16:50 GMT
… an aggressive form of breast cancer, potentially extending their … as well as the hormone therapy fulvestrant.
open image in … breast cancer
PIK3CA mutations are found in 35-40% of HR+ breast cancers … people with metastatic breast cancer the opportunity to live …
-
MEIKE LEONARD: Four in ten women can develop breast cancer that WON'T show up on scans. Here's how to find out if you're at risk
31 May 2025 16:20 GMT
… concluded that the NHS breast cancer screening programme needs urgent … an extra 3,500 breast cancers could be detected each … Zoe Winters, senior consultant breast cancer surgeon at London Breast … deciding whether to take hormone therapy, which can increase the …
-
Breast cancer 3-drug combo gives women ‘precious extra time with loved ones’
31 May 2025 14:29 GMT
… for women with incurable breast cancer by helping them survive … abnormal protein, and a hormone therapy drug, fulvestrant.
Study … giving people with metastatic breast cancer the opportunity to live … support and influencing at Breast Cancer Now, said the drug …
-
Full Arvinas, Pfizer data confirm potential, limits of ‘Protac’ drug in breast cancer
31 May 2025 14:15 GMT
… been treated before with hormone therapy and another type … common treatment for advanced breast cancers that are hormone … in people with advanced breast cancer.
Study researchers also … as treating ESR1-mutated breast cancer remains challenging. Research …